Clinical studies on a vasopressor agent:  metaraminol (aramine).  II.  Observations on its use in the management of shock.
D003295:Convulsive Therapy; D019468:Disease Management; D008680:Metaraminol; D012769:Shock; D013566:Sympathomimetics / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents
D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D008680:Metaraminol
SHOCK/therapy; SYMPATHOMIMETICS/therapeutic use